Cargando…
Improved functionality and potency of next generation BinMLV viral vectors toward safer gene therapy
To develop safer retroviral murine leukemia virus (MLV)-based vectors, we previously mutated and re-engineered the MLV integrase: the W390A mutation abolished the interaction with its cellular tethering factors, BET proteins, and a retargeting peptide (the chromodomain of the CBX1 protein) was fused...
Autores principales: | Van Looveren, Dominique, Giacomazzi, Giorgia, Thiry, Irina, Sampaolesi, Maurilio, Gijsbers, Rik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8433069/ https://www.ncbi.nlm.nih.gov/pubmed/34553002 http://dx.doi.org/10.1016/j.omtm.2021.07.003 |
Ejemplares similares
-
Engineering Next-Generation BET-Independent MLV Vectors for Safer Gene Therapy
por: El Ashkar, Sara, et al.
Publicado: (2017) -
BET-independent MLV-based Vectors Target Away From Promoters and Regulatory Elements
por: El Ashkar, Sara, et al.
Publicado: (2014) -
Targeted editing of the PSIP1 gene encoding LEDGF/p75 protects cells against HIV infection
por: Lampi, Yulia, et al.
Publicado: (2019) -
(Epi)genetic Modifications in Myogenic Stem Cells: From Novel Insights to Therapeutic Perspectives
por: Breuls, Natacha, et al.
Publicado: (2019) -
Morphological and functional analyses of skeletal muscles from an immunodeficient animal model of limb‐girdle muscular dystrophy type 2E
por: Giovannelli, Gaia, et al.
Publicado: (2018)